Navigation Links
Innovative Brain Scanning for Alzheimer's Screening Unveiled
Date:1/23/2008

Clinical Trials with the Neuronetrix' COGNISION Headset to Begin This Month

at the University of Kentucky

LEXINGTON, Ky., Jan. 23 /PRNewswire/ -- Researchers at the University of Kentucky Sanders-Brown Center on Aging are launching an Alzheimer's screening clinical trial with Neuronetrix's innovative brain scanning system, called COGNISION(TM). The study will involve brainwave assessments using a technology called event-related potentials (ERP's). The study is expected to validate the performance of the COGNISION(TM) system and to demonstrate the system's applicability in a primary care setting. Up to 100 Alzheimer sufferers and controls will participate over the next 6-12 months.

During the study patients will wear a sophisticated electronic headset which will record brain activity in response to an auditory stimulus. The process is similar to hearing screening tests performed on newborn infants throughout the country. The data is then uploaded to an online database where a powerful pattern recognition engine will correlate the ERP tests with known brainwave patterns.

The COGNISION(TM) test is expected to be the first approved Alzheimer's disease screening test which directly evaluates a patient's cognitive performance. "We are not looking at a surrogate biomarker which may or may not correlate with Alzheimer's. Instead, we are directly measuring the cognitive deficits caused by the disease," says K.C. Fadem, co-founder of Neuronetrix.

It is generally believed that the drugs used to treat Alzheimer's, such as market leader Aricept(R) from Pfizer, are most effective early in the disease process. Because of this, a national focus has been placed on the importance of Alzheimer's screening to determine optimum treatment paths in the early stage of the disease. At least one organization of medical experts, the AD Screening Discussion Group, has advocated that Alzheimer's disease screenings become a routine part of the application for Medicare.

Alzheimer's disease affects about 5 million Americans with 500,000 new cases reported each year. This number is expected to grow to 16 million by 2050. The CDC recently reported that Alzheimer's disease moved up to 7th place from 8th place among the leading causes of death in 2004, passing influenza and pneumonia.

The Sanders-Brown Center at the University of Kentucky is one of only 32 Alzheimer's Centers of Excellence in the country. Neuronetrix is planning a follow on study to evaluate the COGNISION(TM) System on a commercial scale that will be performed at other Alzheimer's Centers of Excellence including the University of Pennsylvania and Indiana University.

For more information, go to http://www.neuronetrix.com


'/>"/>
SOURCE Neuronetrix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
4. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
7. Video: New Research Discovers Independent Brain Networks Control Human Walking
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
10. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
11. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
Breaking Medicine News(10 mins):